JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. announced establishment of a new subsidiary for investing in the academic laboratory research, scientific test and analysis, training and seminar, and consultancy for research fund application businesses of CDIP (Thailand) Public Company Limited. Furthermore, on 18 April 2023, the Company disclosed information no. JSPCS-23/008 in relation to the resolutions of the Annual General Meeting of Shareholders for the year 2023, which approved the Company the connected and acquisition transactions of the ordinary shares of CDIP by the Company's subsidiary company to be newly established with consideration in cash amounted not exceed than THB 200.0 million.

The date of establishment of subsidiary company 18 August 2023. Company name JSP Pharma Holding Company Limited, Registered capital, number of shares and par value THB 200.0 million, divided to be 2,000,000 shares with par value of THB 100 per share, Source of fund for establishment of subsidiary company The proceeds received from the Initial Public Offering of the capital increase ordinary shares and the Company's working capital amounting to THB 170.0 million and THB 30.0 million, respectively.